Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer.
J Nanobiotechnology. 2022 May 6;20(1):216. doi: 10.1186/s12951-022-01424-7.
J Nanobiotechnology. 2022.
PMID: 35524267
Free PMC article.
[Chinese expert consensus on neoadjuvant therapy for hepatocellular carcinoma (2023 edition)].
Alliance of Chinese Expert Consensus on Neoadjuvant Therapy for Hepatocellular Carcinoma; Committee of Digestive Surgery of Chinese Research Hospital Association; Committee of Liver Cancer, Chinese Anti-Cancer Association.
Alliance of Chinese Expert Consensus on Neoadjuvant Therapy for Hepatocellular Carcinoma, et al.
Zhonghua Wai Ke Za Zhi. 2023 Dec 1;61(12):1035-1045. doi: 10.3760/cma.j.cn112139-20230914-00121.
Zhonghua Wai Ke Za Zhi. 2023.
PMID: 37932138
Review.
Chinese.
Item in Clipboard
[Status and challenges of neoadjuvant immunotherapy for hepatocellular carcinoma].
Xia YX, Cao HS, Tang WW, Wang XH.
Xia YX, et al.
Zhonghua Wai Ke Za Zhi. 2023 Jan 1;61(1):7-12. doi: 10.3760/cma.j.cn112139-20220819-00361.
Zhonghua Wai Ke Za Zhi. 2023.
PMID: 36603877
Chinese.
Item in Clipboard
[Efficacy and safety of neoadjuvant immunotherapy for hepatocellular carcinoma].
Xia YX, Zhang H, Zhang F, Li XC, Rong DW, Tang WW, Cao HS, Zhao J, Wang P, Pu LY, Qian XF, Cheng F, Wang K, Kong LB, Zhang CY, Li DH, Song JH, Yao AH, Wu XF, Wu C, Wang XH.
Xia YX, et al.
Zhonghua Wai Ke Za Zhi. 2022 Jul 1;60(7):688-694. doi: 10.3760/cma.j.cn112139-20220408-00150.
Zhonghua Wai Ke Za Zhi. 2022.
PMID: 35775262
Chinese.
Item in Clipboard
Hypoxia-associated circPRDM4 promotes immune escape via HIF-1α regulation of PD-L1 in hepatocellular carcinoma.
Chen ZQ, Zuo XL, Cai J, Zhang Y, Han GY, Zhang L, Ding WZ, Wu JD, Wang XH.
Chen ZQ, et al.
Exp Hematol Oncol. 2023 Feb 6;12(1):17. doi: 10.1186/s40164-023-00378-2.
Exp Hematol Oncol. 2023.
PMID: 36747292
Free PMC article.
Item in Clipboard
[Application value of machine learning algorithms for predicting recurrence after resection of early-stage hepatocellular carcinoma].
Ji GW, Wang K, Xia YX, Li XC, Wang XH.
Ji GW, et al.
Zhonghua Wai Ke Za Zhi. 2021 Aug 1;59(8):679-685. doi: 10.3760/cma.j.cn112139-20201026-00768. Online ahead of print.
Zhonghua Wai Ke Za Zhi. 2021.
PMID: 34192861
Chinese.
Item in Clipboard
Cite
Cite